Home Cart Sign in  
Chemical Structure| 895519-90-1 Chemical Structure| 895519-90-1

Structure of Flumatinib
CAS No.: 895519-90-1

Chemical Structure| 895519-90-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Flumatinib is a multi-kinase inhibitor with IC50 Values of 1.2 nM, 307.6 nM and 2662 nM for c-Abl, PDGFRβ and c-Kit respectively.

Synonyms: HHGV678

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Flumatinib

CAS No. :895519-90-1
Formula : C29H29F3N8O
M.W : 562.59
SMILES Code : O=C(NC1=CC(NC2=NC=CC(C3=CC=CN=C3)=N2)=C(C)N=C1)C4=CC=C(CN5CCN(C)CC5)C(C(F)(F)F)=C4
Synonyms :
HHGV678
MDL No. :MFCD18633213

Safety of Flumatinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Flumatinib

RTK

Isoform Comparison

Biological Activity

Description
Flumatinib (HHGV678) is an oral, selective Bcr-Abl inhibitor. It effectively targets c-Abl, PDGFRβ, and c-Kit with IC50 values of 1.2 nM, 307.6 nM, and 665.5 nM, respectively [1].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04375683 Acute Lymphocytic Leukemia, Ad... More >>ult B-Cell|BCR-ABL1 Fusion Protein Expression Less << PHASE3 UNKNOWN 2022-12-30 Department of Hematology, Zhon... More >>gda Hospital Southeast University, Institute of Hematology Southeast University, Nanjing, Jiangsu, 210009, China|Department of Hematology, Zhongda Hospital Southeast University, Institute of Hematology Southeast University, Nanjing, Jiangsu, 210009, China Less <<
NCT04677439 Flumatinib|Chronic Myeloid Leu... More >>kemia, Chronic Phase|Imatinib Less << PHASE4 UNKNOWN 2023-12-30 The Second People's Hospital o... More >>f Shenzhen, Shenzhen, Guangdong, 518035, China Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.78mL

0.36mL

0.18mL

8.89mL

1.78mL

0.89mL

17.77mL

3.55mL

1.78mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories